Richard Fogel, MD, executive vice president and chief clinical officer at St. Louis-based Ascension, will transition to the new role of chief health outcomes officer. The transition will take place on ...
Anish Suri, Ph.D., president & chief scientific officer (CSO) of Cue Biopharma, to transition to principal research and immunology advisor BOSTON, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc.